University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 19 of 24
Pilot Study Effect of Sulfasalazine on Glutamate Levels by(Magnetic Resonance Spectroscopy)MRS in Patients With Glioma
NCT01577966
Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study
NCT01512264
The Bottle Study: Infant Weight Gain During Use of Novel Versus Typical Infant Feeding Bottles
NCT01526018
MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
NCT01547481
Neo-Penotran Forte Vaginal Suppository for Vaginal Trichomoniasis
NCT01361048
The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
NCT01464840
Mitoferrin-1 Expression in Erythropoietic Protoporphyria (Porphyria Rare Disease Clinical Research Consortium (RDCRC))
NCT01880983
Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial
NCT01242462
Healthcare Provider Attitudes Towards Patients With Substance Use Before and After Implementation of the SBIRT Model in the Emergency Room
NCT01661478
The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain
NCT00885976
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
NCT01438307
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia
NCT01557595
Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
NCT01661517
Left Ventricular Torsional Hysteresis: A Global Parameter for Diastolic Function
NCT01431027
Sexually Transmitted Infections Among African American Women Who Have Sex With Women
NCT01546714
Re-feeding Gastric Residuals in Preterm Infants
NCT01420263
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
NCT01404702
Withdrawal Exposure With Withdrawal Regulation Training for Smoking Cessation
NCT02192762
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient
NCT01277250
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
NCT01401829
Development of Post Traumatic Stress Disorder After Natural Disaster
NCT01661452
Comfort Evaluation of Non-Invasive Respiratory Monitor Interfaces
NCT01494844
Bone Mineral Density in HIV+ Patients
NCT01378494
Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects
NCT01349114
Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
NCT01330108
The Alabama NSAIDs Patient Safety Survey, Phase II: Reducing Disparities in Risk Awareness and Communication
NCT01352832
Performance of MicroTextured Dental Implants
NCT01821417
A Case Control Study of Women With Multiple Sexual Partners
NCT01578915
Routine Clinical Screening for Substance Use Disorders in the Emergency Room Setting
NCT01661465
Reducing Care-Resistant Behaviors During Oral Hygiene in Persons With Dementia
NCT01363258
Impact of Food Additives on Phosphorus Metabolism
NCT01394146
A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients
NCT01770626
African American Children, Glycemic Control, and Type 2 Diabetes
NCT01325987
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study)
NCT01410643
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
NCT01307891
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
NCT01381926
Comparison of Three Toothpastes for the Prevention and Reduction of White Spot Lesions
NCT03440996
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
NCT01578941
Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
NCT00827164
Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse
NCT01431040
Oronasopharyngeal Suction Versus Simple Nose and Mouth Wiping in Term Newborns
NCT01197807
A Study to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments to Promote Tissue Healing
NCT01822223
Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002)
NCT01252797
Medifast 5 & 1 Plan
NCT01211301
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
NCT01247298
Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids
NCT01378689
Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World
NCT02310880
Physical Activity, Fatigue, Sleep, and Inflammation
NCT01147367
Journey to Better Health
NCT02938312
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders
NCT01169324
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.